Salute e Benessere

Molecular Diagnostics Market to be Worth $31.9 Billion by 2030: Grand View…

Key Industry Insights & Findings from the report: Key Industry Insights & Findings from the report: Read 270-page market research report, " Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By Technology (PCR, Sequencing, INAAT, TMA), By Application, By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research. Molecular Diagnostics Market Growth & Trends Molecular diagnostics...
PR Newswire
05/07/2023

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q2 2023

Sales in Zinzino's sales markets increased by 24% in the second quarter of 2023 compared with the same period last year and amounted to SEK 384.0 (308.5) million. Total revenues in the Group increased by 23% in the second quarter and amounted to SEK 404.5 (329.5) million. Sales in Zinzino's sales markets increased by 24% in the second quarter of 2023 compared with the same period last year and amounted toSEK 384.0(308.5) million. Total revenues in the Group increased by 23% in the second...
PR Newswire
05/07/2023

Biobanking Industry Expects Cell Banks to Revolutionize Healthcare - Grand View…

Order your copy of the Free Sample of "Biobanking Industry Data Book - Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA & RNA Banking Services Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research Order your copy of the Free Sample of " Biobanking Industry Data Book - Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA & RNA Banking Services Market Size, Share, Trends…
PR Newswire
05/07/2023

Biocomposites invests in Renovos Biologics - developers of the RENOVITE®…

Biocomposites, CEO, Michael Harris will join Renovos Biologics Board of Directors Biocomposites, CEO,Michael Harriswill join Renovos Biologics Board of Directors KEELE,England,July 5, 2023/PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces it has taken a minority-share interest inRenovos Biologics (Renovos),...
PR Newswire
05/07/2023

BGI CEO Yin Ye Advocates for Global Technology Sharing

The COVID-19 pandemic demonstrated the importance of the world coming together to share technology and information to solve a critical health issue. "During the pandemic, if we did not share the technology, the public health applications, vaccines and IVD kits, then the virus would definitely occupy the world," said Dr Yin. The COVID-19 pandemic demonstrated the importance of the world coming together to share technology and information to solve a critical health issue. "During…
PR Newswire
05/07/2023

VALNEVA - Declaration of shares and voting rights: June 30, 2023

VALNEVADeclaration of shares and voting rights June 30 , 2023__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment BDeclaration date: July 5, 2023 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the change...
Nasdaq GlobeNewswire
05/07/2023

apoQlar secures funding led by YZR Capital, revolutionizes surgical care through…

The partnership with YZR Capital will enable apoQlar to further enhance its augmented reality technology, strengthen its market presence, and expand its global footprint. Additionally, the investment will support apoQlar's collaborative efforts with healthcare providers and surgical teams to improve patient outcomes and enhance surgical practices. The partnership with YZR Capital will enable apoQlar to further enhance its augmented reality technology, strengthen its market presence, and…
PR Newswire
05/07/2023

Gout Market to Accelerate Positively, Estimates DelveInsight | Key Companies…

Key Takeaways from the Gout Market Report Key Takeaways from the Gout Market Report Discover which therapies are expected to grab the major gout market share @Gout Market Report Gout Overview Gout is a type of inflammatory arthritis that is quite frequent. It is caused by a crystal known as uric acid. Gout is characterised by joint pain and edoema in one or more joints. The big toe is usually affected. However, it can also be present in other joints such as the knee, ankle,...
PR Newswire
04/07/2023

Groupe Casino: Update on new money equity offers

Update on new money equity offers Paris, 4 July 2023In response to the rumours circulating in the press, Casino has decided to accelerate the timetable for the distribution of proposals, and today made public the content of the proposals received from EP Global Commerce a.s. and Fimalac, as well as from 3F Holding. In any event, the current shareholders of Casino will be massively diluted and Rallye will no longer control Casino. A presentation comparing these two offers is being...
Nasdaq GlobeNewswire
04/07/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2023

Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode) IPSEN549300M6SGDPB4Z94P1126/06/2023FR00102591501,272108.60AQEUIPSEN549300M6SGDPB4Z94P1126/06/2023...
Nasdaq GlobeNewswire
04/07/2023

Plant-based Biologics Market Predicted to Make a Strong Comeback After the…

Global Plant-based Biologics Market Forecast Analysis: Global Plant-based Biologics Market Forecast Analysis: As per the report published by Research Dive, theglobal plant-based biologics marketis anticipated to generate a revenue of$182.9 millionand grow at a CAGR of 4.8% over the analysis timeframe from 2022 to 2031. Segments of the Plant-based Biologics Market The report has divided the plant-based biologics market into the following segments: To get access...
PR Newswire
04/07/2023

Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior…

Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025(ISIN: BE6325746855)Liege, Belgium ,4 July2023–[17:45 CEST]– Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the " Company " or " Mithra "), a company dedicated to Women's Health, confirms to Bondholders that, in accordance with the terms and conditions of the Company's EUR 125,000,000 senior unsecured convertible bonds due...
Nasdaq GlobeNewswire
04/07/2023

CT/NG Testing Market worth $2.7 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104333528 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104333528 Browse in-depth TOC on "CT/NG Testing Market" 95 - Tables 40 - Figures 200 - Pages CT/NG Testing Market Scope: Assays & Kits segment is expected to account for the largest share in 2022. Based on product, the CT/NG testing market is segmented into assays...
PR Newswire
04/07/2023

Transactions in connection with share buy-back program

Company announcement no. 33 - 234 July 2023 Transactions in connection with share buy-back program On 8 May 2023 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 17 - 23. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbor rules...
Nasdaq GlobeNewswire
04/07/2023

Primary Biliary Cholangitis Therapeutics Market to Reach $1.36 Billion…

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/109023 Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/109023 Prime determinants of growth Increase in awareness regarding primary biliary cholangitis disease in developing countries, rise in demand of primary biliary cholangitis therapeutics, and rise in research and development of primary biliary cholangitis therapeutics drive the growth of the global primary biliary...
PR Newswire
04/07/2023

Pediatric Home Healthcare Market to Reach $71.2 Billion, Globally, by 2032 at…

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/108047 Download Sample Copy-https://www.alliedmarketresearch.com/request-sample/108047 Prime determinants of growth Rise in prevalence of cancer and chronic disease in children, growing preference for home-based care and increasing awareness among parents, caregivers, and healthcare professionals about the benefits of pediatric home healthcare acts as a key driving factor for the growth of the global...
PR Newswire
04/07/2023

Glucose Monitoring Devices Market Zooms Towards Billion-Dollar Valuation…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=17545 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=17545 Browse in-depth TOCon" Glucose Monitoring Devices Market " 202 - Pages 126 – Tables 37 – Figures Glucose Monitoring Devices Market: Rising Incidence of Diabetes and Technological Advancements Fueling Market Growth Glucose Monitoring Devices, including testing strips, glucose meters, and...
PR Newswire
04/07/2023

European Commission Grants Conditional Marketing Authorization for Taiho's…

CCA is an aggressive cancer of the bile ducts of the liver. While rare – in Europe, approximately 6.000-8.000 people are diagnosed with CCA1 – this disease is associated with poor outcomes and is growing in prevalence worldwide2, underscoring the need for new treatment options. CCA is an aggressive cancer of the bile ducts of the liver. While rare – inEurope, approximately 6.000-8.000 people are diagnosed with CCA 1– this disease is associated with poor outcomes and is growing in...
PR Newswire
04/07/2023

Hansa Biopharma AB recognizes a write-up of SEK 1.430 billion in intangible…

The fair value of the asset has been independently determined by applying the so-called "income approach" which calculates the value on the basis of discounted future economic benefits expected to be provided by the asset. The fair value of the asset has been independently determined by applying the so-called "income approach" which calculates the value on the basis of discounted future economic benefits expected to be provided by the asset. The intangible asset will be…
PR Newswire
04/07/2023

PharmaLedger Reaches 30+ Members Demonstrating the Ecosystem Trend in Digital…

"The growing and increasingly diverse PLA membership reaffirms our belief in the power of building an ecosystem as a progressive path--and a fundamental necessity--for enlightened organizations. It fills me with great joy to witness the growing relevance of PharmaLedger and to see the industry embracing our message of the need for a shared infrastructure in digital healthcare." Clarisse Dias da Mota, VP EO&S, PharmaLedger Association "The growing and increasingly diverse PLA…
PR Newswire
04/07/2023

Orion publishes Half-Year Financial Report for January–June 2023 on Monday 17…

ORION CORPORATIONPRESS RELEASE4 July 2023 at 12.00 EEST Orion publishesHalf-Year Financial Report for January–June 2023 on Monday 17 July 2023Orion will publish Half-Year Financial Report for January–June 2023 on Monday, 17 July 2023 at approximately 12.00 noon EEST. The release and related presentation material will be available on the company's website atwww.orion.fi/en/investorsafter publishing. Webcast and conference call A webcast and a...
Nasdaq GlobeNewswire
04/07/2023

CCube Solutions appoints seasoned healthcare software business leader Alistair…

Alistair then joined Docman (now Advanced), leading the company's transition from an on-premise system supplier to one of the largest providers of public cloud SaaS solutions to the NHS. Prior to joining CCube, he was the Vice President of the Health and Care division at Advanced. Alistair then joined Docman (now Advanced), leading the company's transition from an on-premise system supplier to one of the largest providers of public cloud SaaS solutions to the NHS. Prior to joining CCube, he…
PR Newswire
04/07/2023

IBT announces outcome of its rights issue

The Board of Directors of Infant Bacterial Therapeutics AB (publ) (“IBT” or the “Company”) today announces the outcome of the Company's rights issue of approximately SEK 100 million (the “Rights Issue”) , for which the subscription period ended on 29 June 2023. The outcome of the Rights Issue shows that the subscription by exercise of subscription rights and the applications for subscription without subscription rights in total correspond to approximately...
Nasdaq GlobeNewswire
04/07/2023

Management in Vistin Pharma ASA purchases shares

4 July 2023: Vistin Pharma ASA (the “Company”) has on 4 July 2023 sold shares to members of its management team for its long-term incentive plan (LTIP), as approved by the general meeting on the 22 May 2023, at a price of NOK 23,00 per share (the “Purchase Price”). The following persons discharging managerial responsibilities (primary insiders) have purchased shares:Kjell-Erik Nordby (CEO): 40 000 shares, each at a price equal to the Purchase Price After this transaction, Kjell-Erik Nordby...
Nasdaq GlobeNewswire
04/07/2023
Altri  Comunicati